Tetraspanin32 ( TSPAN 32) is downregulated in rheumatoid arthritis: Evidence from animal models and patients
Scandinavian Journal of Immunology · 2024
DOI: 10.1111/sji.13410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Katia Mangano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Tetraspanins, Arthritis, Experimental, Down-Regulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to investigate the role of TSPAN32, a member of the tetraspanin family, in rheumatoid arthritis (RA). The objective was to assess the expression levels of TSPAN32 in experimental RA models and in RA patient immune cells, exploring its potential as a regulatory factor in RA pathogenesis. The study employed adjuvant‐induced arthritis in rats and collagen‐induced arthritis (CIA) in mice as experimental models. Ex vivo analyses included evaluating TSPAN32 expression in immune cells at different stages of the disease. In silico data analysis involved examining transcriptomic datasets from drug‐naïve and treated RA patients to correlate TSPAN32 expression with clinical parameters. TSPAN32 overexpression experiments in splenocytes from CIA mice aimed to demonstrate its functional impact on antigen‐specific immune responses. The animal models revealed a significant downregulation of TSPAN32, particularly in synovial‐infiltrating T cells. Also, TSPAN32 overexpression inhibited pro‐inflammatory cytokine production in splenocytes. In RA patients, TSPAN32 was consistently downregulated in circulating and synovial‐infiltrating T cells, as well as in CD8+ T cells, B cells and NK cells. Drug treatment did not significantly alter TSPAN32 levels. Negative correlations were observed between TSPAN32 expression and inflammatory markers (CRP, ESR) and clinical scores (SDAI) in RA patients. This study suggests that reduced TSPAN32 expression characterizes pathogenic T‐cell populations in RA, highlighting its potential as biomarker for inflammation and disease activity. TSPAN32 may play a crucial role in shaping adaptive immune responses in RA, opening avenues for novel therapeutic strategies targeting this tetraspanin family member.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
- University Center for Health Science, Department of Molecular Biology and Genomics, University of Guada-lajara, Guadalajara, Jalisco, Mexico.
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
ORCID-Profile: Jose' Francisco Munoz-Valle, Paolo Fagone
Zitieren
APA
Mangano, K., Munoz-Valle, J. F., Palafox-Sánchez, C. A., Petralia, M. C., Leone, G. M., Fagone, P., & Nicoletti, F. (2024). Tetraspanin32 ( TSPAN 32) is downregulated in rheumatoid arthritis: Evidence from animal models and patients. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13410
Vancouver
Mangano K, Munoz-Valle JF, Palafox-Sánchez CA, Petralia MC, Leone GM, Fagone P, et al. Tetraspanin32 ( TSPAN 32) is downregulated in rheumatoid arthritis: Evidence from animal models and patients. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13410
BibTeX
@article{Mangano2024,
author = {Mangano, Katia and Munoz-Valle, Jose' Francisco and Palafox-Sánchez, Claudia Azucena and Petralia, Maria Cristina and Leone, Gian Marco and Fagone, Paolo and Nicoletti, Ferdinando},
title = {Tetraspanin32 ( TSPAN 32) is downregulated in rheumatoid arthritis: Evidence from animal models and patients},
journal = {Scandinavian Journal of Immunology},
year = {2024},
doi = {10.1111/sji.13410}
}
EUVIMED